RELIVE Informed Consent Study

National Institute of Allergy and Infectious Diseases (NIAID)

Status: Completed

Conditions: Tissue Donors; Living Donors

Treatments: Procedure: Organ Donation

Study type: Observational

Funder types: NIH

Identifiers

NCT01742234

DAIT RELIVE 03

Details and patient eligibility

About

An organ transplant is frequently the best option and, in some cases, the only option to save the lives of transplant recipients. Receiving an organ from a living donor eliminates the need to wait for a deceased donor, an option that many transplant recipients do not survive. However, donating an organ presents health concerns to the donor as well. This study will use surveys to evaluate the understanding of risk and psychological pressure that living organ donors felt when making the decision to donate. It will also compare participants' answers across geographic, racial and socio-economic backgrounds.

Enrollment: 624 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Living donor of a kidney or lung

Exclusion criteria

• Unable to give informed consent

Trial design

624 participants in 2 patient groups

Kidney Donors

Description:

People who will donate a kidney at the University of Minnesota, Mayo Clinic, or University of Alabama

Treatment:

Procedure: Organ Donation

Lung Donors

Description:

People who will donate a lung at the Washington University School of Medicine or the University of Southern California

Treatment:

Procedure: Organ Donation